Trivant Custom Portfolio Group, LLC Mannkind Corp Transaction History
Trivant Custom Portfolio Group, LLC
- $174 Billion
- Q1 2025
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 100 shares of MNKD stock, worth $430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 150
33.33%
Holding current value
$430
Previous $965,000
47.88%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MNKD
# of Institutions
275Shares Held
172MCall Options Held
1.37MPut Options Held
248K-
Black Rock Inc. New York, NY22.6MShares$97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$74.5 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$40.7 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$37.6 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY7.79MShares$33.5 Million7.16% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.11B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...